PatentsGlobal
BioStem Technologies Secures Four New U.S. Design Patents for Fenestrated Placental Allograft Innovations
BioStem Technologies, a regenerative medicine company specializing in perinatal tissue allografts, announced the issuance of four U.S. design patents covering its proprietary fenestrated human placental allograft technologies. These patents bolster the company’s IP portfolio by safeguarding innovative designs that imp…
Wednesday, July 8, 2026